Racial Differences in Response to Antiretroviral Therapy for HIV Infection: An AIDS Clinical Trials Group (ACTG) Study Analysis | Zendy

Heather J. Ribaudo | Zendy; Kimberly Y. Smith | Zendy; Gregory K. Robbins | Zendy; Charles Flexner | Zendy; Richard Haubrich | Zendy; Yun Chen | Zendy; Margaret A. Fischl | Zendy; Bruce R. Schackman | Zendy; Sharon A. Riddler | Zendy; Roy M. Gulick | Zendy

Open Access

Racial Differences in Response to Antiretroviral Therapy for HIV Infection: An AIDS Clinical Trials Group (ACTG) Study Analysis

Author(s) -

Heather J. Ribaudo,

Kimberly Y. Smith,

Gregory K. Robbins,

Charles Flexner,

Richard Haubrich,

Yun Chen,

Margaret A. Fischl,

Bruce R. Schackman,

Sharon A. Riddler,

Roy M. Gulick

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit595

Subject(s) - medicine , hazard ratio , confounding , confidence interval , randomized controlled trial , immunology

In the United States, black individuals infected with human immunodeficiency virus (HIV) have higher rates of virologic failure on antiretroviral therapy (ART) and of death compared to white individuals. The cause for these disparities is uncertain. We sought to examine differences in virologic outcomes among antiretroviral-naive clinical trial participants starting randomized ART and to investigate factors to explain the differences.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research